Regular aspirin use does not reduce risk of cognitive decline

Journal of the American Geriatrics Society

Volumn 63, Issue 2, 2015, Pages 390-392

  Kelley, Brendan J ^a   McClure, Leslie A ^b   Unverzagt, Frederick W ^c   Kissela, Brett ^d   Kleindorfer, Dawn ^d   Howard, George ^b   Wadley, Virginia G ^e  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e and Clinical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

AGED; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; LEARNING; LETTER; MAJOR CLINICAL STUDY; MALE; MEMORY; NATIONAL HEALTH ORGANIZATION; NEUROPROTECTION; RISK FACTOR; WORD LIST RECALL; COGNITION DISORDERS; COHORT ANALYSIS; INCIDENCE; MIDDLE AGED; PSYCHOLOGY; STROKE;

AGED; ASPIRIN; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; STROKE;

EID: 84923259871     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13271     Document Type: Letter

References (10)

1. Wadley VG, McClure LA, Howard VJ, et al. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke 2007; 38: 1143-1147.
2. Kelley BJ, McClure LA, Letter AJ, et al. Report of stroke-like symptoms predicts incident cognitive impairment in a stroke-free cohort. Neurology 2013; 81: 113-118.
3. Howard VJ, Cushman M, Pulley L, et al. The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and design. Neuroepidemiology 2005; 25: 135-143.
4. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220-2241.
5. Jonker C, Comijs HC, Smit JH,. Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study. Neurobiol Aging 2003; 24: 583-588.
6. Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156: 445-453.
7. Stewart WF, Kawas C, Corrada M, et al. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997; 48: 626-632.
8. Kang JH, Cook N, Manson J, et al. Low dose aspirin and cognitive function in the Women's Health Study cognitive cohort. BMJ 2007; 334: 987.
9. Szekely CA, Breitner JC, Fitzpatrick AL, et al. NSAID use and dementia risk in the Cardiovascular Health Study: Role of APOE and NSAID type. Neurology 2008; 70: 17-24.
10. Price JF, Stewart MC, Deary IJ, et al. Low dose aspirin and cognitive function in middle aged to elderly adults: Randomised controlled trial. BMJ 2008; 337: a1198.